Home 9 Pharmacovigilance 9 Local Pharmacovigilance Representation

Local Pharmacovigilance Representation

 
  • Appointment of Lead LSO and Deputy LSO for each country and their nomination to the local Competent Authority;
  • 24/7 availability, where required;
  • Weekly monitoring of locally published scientific and medical literature;
  • Local processing of Individual Case Safety Reports (ICSRs), including reporting to the local Competent Authority, where applicable;
  • National regulatory intelligence;
  • Local support in Risk Management Plans (RMPs) and Periodic Safety Update Reports (PSURs) handling;
  • Delivery of pharmacovigilance training to local Marketing Authorisation Holders personnel.

All Post-Authorization Services

Ensured Patient Safety.

Recent Insights

Learn from Biomapas' experts and let us know what you'd like to hear about!

Challenges in early phase oncology trials
Clinical Trials Regulation
Challenges in early phase oncology trials